Amgen AMGN reported first-quarter 2025 adjusted earnings of $4.90 per share, which beat the Zacks Consensus Estimate of $4.16 ...

KY1005 – now renamed amlitelimab – is one of a handful of new drugs targeting OX40 ligand, an immune system regulator delivered by intravenous infusion once every 28 days. It is also being ...

In recent weeks, top health officials have floated an idea for bringing down prescription drug costs in the United States: ...

Roche posted higher sales that beat analysts’ expectations on higher demand for its key drugs.

Roche posted higher-than-expected first-quarter sales, driven by robust demand for its key drugs, as the company takes active steps to preempt looming U.S. import tariffs. To strengthen its U.S ...

Telangana Anti Narcotics Bureau apprehended Ezeonyili Franklin Uchenna, a Nigerian drug supplier, in Hyderabad after he had ...

Roche posted higher first-quarter sales that beat analysts' expectations on higher demand for its key drugs. The Swiss pharmaceutical giant said Thursday that sales rose to 15.44 billion Swiss ...